PATENT CLAIM ANALYSIS

Application Number: 15900589
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["435", "069100"]

Abstract:
The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.

Claim (Index 44):
A method for isolating  S. aureus  and/or  S. epidermidis  bacteria comprising contacting a sample with an antibody or functional part thereof, wherein the antibody or functional part thereof comprises a heavy chain variable domain and a light chain variable domain comprising:\n (a) a heavy chain CDR1 sequence RFAMS (SEQ ID NO:1), and (b) a heavy chain CDR2 sequence SINNGNNPYYARSVQY (SEQ ID NO:2) or SINSGNNPYYARSVQY (SEQ ID NO:60), and (c) a heavy chain CDR3 sequence DHPSSGWPTFDS (SEQ ID NO:3), and (d) a light chain CDR1 sequence RASENVGDWLA (SEQ ID NO:4), and (e) a light chain CDR2 sequence KTSILES (SEQ ID NO:5), and (f) a light chain CDR3 sequence QHYXRFPYT (SEQ ID NO:6), wherein X is I or M.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15246301', '14728826', '14981643', '13786215', '14103715']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6600471635079421
- 35 USC 102 Novelty (BERT): 0.5867844433902041
- Combined Prediction Score: 0.6527208914961683
- Mean Citation Score: 487.27792199999993
- Max Citation Score: 497.9231
- Similarity Product: 445.16666467320914

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test